Physician profile
Robert A James
NPI 1699747006
$1,927.10
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,573 · 2020: $278 · 2021: $35.79 · 2024: $39.99.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $39.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $39.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $394.17 | 2019-2020 | |
| Pfizer INC. | $249.98 | 2019-2024 | |
| Novo Nordisk INC | $169.27 | 2019 | |
| Amgen INC. | $146.74 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $145.44 | 2019-2020 | |
| Lilly USA, LLC | $135.20 | 2019 | |
| Astellas Pharma US INC | $94.23 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $93.01 | 2019-2020 | |
| Allergan, INC. | $66.37 | 2019-2020 | |
| Amarin Pharma, INC. | $49.94 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $44.90 | 2019-2020 | |
| Kowa Pharmaceuticals America, INC. | $42.71 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $41.83 | 2019 | |
| Sanofi-Aventis U.S. LLC | $38.58 | 2019-2020 | |
| Abbvie INC. | $35.79 | 2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $35.43 | 2019-2020 | |
| Hologic Sales and Service, LLC | $25.56 | 2019 | |
| Vivus LLC | $24.93 | 2019 | |
| Ibsa Pharma INC. | $16.87 | 2019 | |
| Eisai INC. | $16.69 | 2019 | |
| Endo Pharmaceuticals INC. | $15.37 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $15.00 | 2019 | |
| Currax Pharmaceuticals LLC | $14.70 | 2019 | |
| Glaxosmithkline, LLC. | $14.39 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert James listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.